View PDF of blog article here
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
Dr. Peter Slavin, president of Mass. General Hospital: "We don’t want our faculty being on the road as hired guns."
In its response to Sen. Grassley’s probe, The National Alliance on Mental Illness (NAMI) acknowledges that a majority of its funds over the last five years, 56% on average, have come from drug corporations.
Children have been dying from exposure to psychostimulant drugs as the FDA looked the other way:
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
